Skip to content

Lasev Pharma Consulting: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Lasev Pharma Consulting

BE 1013.507.072
NACE 70.200, Business and other management consultancy
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€53,920
2024 · €12,282+€41,638
Equity
€68,160
2024 · €15,282+€52,879
Cash
€67,961
2024 · €11,116+€56,846
Balance sheet total
€92,844
2024 · €32,467+€60,377

Largest movements

2024 to 2025
Assets
  • Cash +€56,846

    up €56,846 (+511%), from €11,116 to €67,961

    mainly Net result for the year (+€53,920) and Tax, wage and social debts (+€5,743)

  • Deferred charges and accrued income +€1,861

    up €1,861 (+262%), from €711 to €2,572

  • Receivables within one year +€1,807

    up €1,807 (+10.0%), from €18,150 to €19,957

    of which Other amounts receivable: +€1,807

Equity and liabilities
  • Reserves +€52,879

    up €52,879 (+431%), from €12,282 to €65,160

  • Tax, wage and social debts +€5,743

    up €5,743 (+49.7%), from €11,546 to €17,289

  • Trade debts +€3,920

    up €3,920 (+161%), from €2,434 to €6,354

  • Other debts -€2,164

    down €2,164 (-67.5%), from €3,206 to €1,041

Income statement
  • Gross operating margin +€61,607

    up €61,607 (+374%), from €16,454 to €78,061

  • Taxes +€18,132

    up €18,132 (+542%), from €3,348 to €21,481

  • Financial charges +€896

    up €896 (+135%), from €665 to €1,561

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €12,282
Gross operating margin +€61,607
Depreciation -€579
Other operating charges -€362
Financial income +€0
Financial charges -€896
Taxes -€18,132
Result 2025 €53,920
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€58,448
Investment -€561
Financing -€1,041
Cash 2024 €11,116
Net result for the year +€53,920
Depreciation +€698
Receivables within one year -€1,807
Deferred charges and accrued income -€1,861
Trade debts +€3,920
Tax, wage and social debts +€5,743
Other debts -€2,164
Investment in fixed assets (net) -€561
Contributions, distributions and other -€1,041
Cash 2025 €67,961
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €32,467 €92,844 +€60,377 +186%
Fixed assets 21/28 €2,490 €2,354 -€136 -5.5%
Tangible fixed assets 22/27 €2,490 €2,354 -€136 -5.5%
Plant, machinery and equipment 23 €1,899 €1,499 -€400 -21.1%
Furniture and vehicles 24 €591 €855 +€264 +44.6%
Current assets 29/58 €29,977 €90,491 +€60,514 +202%
Amounts receivable within one year 40/41 €18,150 €19,957 +€1,807 +10.0%
Trade receivables 40 €18,150 €18,150 = 0.0%
Other amounts receivable 41 - €1,807 +€1,807
Cash at bank and in hand 54/58 €11,116 €67,961 +€56,846 +511%
Deferred charges and accrued income 490/1 €711 €2,572 +€1,861 +262%
Total equity and liabilities 10/49 €32,467 €92,844 +€60,377 +186%
Equity 10/15 €15,282 €68,160 +€52,879 +346%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €12,282 €65,160 +€52,879 +431%
Distributable reserves 133 €12,282 €65,160 +€52,879 +431%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €17,185 €24,684 +€7,499 +43.6%
Amounts payable within one year 42/48 €17,185 €24,684 +€7,499 +43.6%
Trade debts 44 €2,434 €6,354 +€3,920 +161%
Suppliers 440/4 €2,434 €6,354 +€3,920 +161%
Taxes, remuneration and social security 45 €11,546 €17,289 +€5,743 +49.7%
Taxes 450/3 €11,546 €17,289 +€5,743 +49.7%
Other amounts payable 47/48 €3,206 €1,041 -€2,164 -67.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €118 €698 +€579 +490%
Other operating charges 640/8 €41 €402 +€362 +883%
Gross operating margin 9900 €16,454 €78,061 +€61,607 +374%
Operating profit (loss) 9901 €16,295 €76,961 +€60,666 +372%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €665 €1,561 +€896 +135%
Recurring financial charges 65 €665 €1,561 +€896 +135%
Profit (loss) for the period before taxes 9903 €15,630 €75,401 +€59,771 +382%
Income taxes 67/77 €3,348 €21,481 +€18,132 +542%
Profit (loss) for the period 9904 €12,282 €53,920 +€41,638 +339%
Profit (loss) for the period to be appropriated 9905 €12,282 €53,920 +€41,638 +339%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.